FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hana Golding

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Swati Verma; Surender Khurana; Ashok Munjal; Ted M Ross; Donald M Carter; Corey J Crevar; Milena Dimitrova; Juan Fontana; Hana Golding
Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.
Surender Khurana; Bonnie B Blomberg; Daniela Frasca; Hana Golding
AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans.
Marina Zaitseva; Tatiana Romantseva; Lev Sirota; Joel Beren; Ksenia Blinova; Debbie Drane; Hana Golding
Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hana Golding (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Swati Verma; Surender Khurana; Ashok Munjal; Ted M Ross; Donald M Carter; Corey J Crevar; Milena Dimitrova; Juan Fontana; Hana Golding
Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.
Journal of virology 2012;86(22):12283-93.
2012: Surender Khurana; Bonnie B Blomberg; Daniela Frasca; Hana Golding
AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans.
PLoS pathogens 2012;8(9):e1002920.
2012: Marina Zaitseva; Tatiana Romantseva; Lev Sirota; Joel Beren; Ksenia Blinova; Debbie Drane; Hana Golding
Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo.
Vaccine 2012;30(32):4859-65.
2012: Nitin Verma; Ted M Ross; Donald M Carter; Corey J Crevar; Milena Dimitrova; Hana Golding; Surender Khurana
Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.
Journal of virology 2012;86(10):5515-22.
2012: Surender Khurana; KAWSAR TALAAT; Nitin Verma; Ruth A Karron; Hana Golding
Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.
The Journal of infectious diseases 2012;205(4):610-20.
2012: Marina Zaitseva; Senta Kapnick; Hana Golding
Measurements of vaccinia virus dissemination using whole body imaging: approaches for predicting of lethality in challenge models and testing of vaccines and antiviral treatments.
Methods in molecular biology (Clifton, N.J.) 2012;890():161-76.
2011: Surender Khurana; Pretty Sasono; Tran Hien Nguyen; Quynh Mai Le; Thanh Liem Nguyen; Quang Thai Pham; Van Kinh Nguyen; Annette Fox; Peter Horby; Hana Golding
H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance.
Journal of virology 2011;85(23):12455-63.
2011: Surender Khurana; Lisa R King; Eloi Kpamegan; Jody Manischewitz; Steven Pincus; Ramadevi Raghunandan; Gale Smith; Nitin Verma; Swati Verma; Jian Wu; Gregory Glenn; Hana Golding
H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.
Journal of virology 2011;85(21):10945-54.
2011: Marina Zaitseva; Senta M Kapnick; Lisa R King; Shantha Kodihalli; Johan Lantto; Jody Manischewitz; Michael Merchlinsky; Clement A Meseda; Henriette Nielsen; John Scott; Elisabeth Shotwell; Jerry P Weir; Hana Golding
Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs.
Journal of virology 2011;85(17):9147-58.
2011: Surender Khurana; Lisa R King; Christopher Larkin; Jody Manischewitz; William McCormick; Alasdair C Steven; Swati Verma; Juan Fontana; Rajesh K Gupta; Manju B Joshi; Hana Golding
Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines.
Vaccine 2011;29(34):5657-65.
2011: Surender Khurana; Nitin Verma; Jonathan W Yewdell; Anne Katrin Hilbert; Flora Castellino; Maria Lattanzi; Giuseppe Del Giudice; Rino Rappuoli; Hana Golding
MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.
Science translational medicine 2011;3(85):85ra48.
2011: Surender Khurana; Swati Verma; Nitin Verma; Corey J Crevar; Donald M Carter; Jody Manischewitz; Lisa R King; Ted M Ross; Hana Golding
Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets.
Journal of virology 2011;85(3):1246-56.
2011: Joseph W Golden; Hana Golding; John Ballantyne; Robert W Fisher; Senta Kapnick; Malgorzata G Mikolajczyk; Marina Zaitseva; Jay W Hooper
Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.
Virology journal 2011;8():441.
2011: Hanxin Lu; Surender Khurana; Nitin Verma; Jody Manischewitz; Lisa King; John H Beigel; Hana Golding
A rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cells.
PloS one 2011;6(2):e17297.
2011: Philip R Dormitzer; Grazia Galli; Flora Castellino; Hana Golding; Surender Khurana; Giuseppe Del Giudice; Rino Rappuoli
Influenza vaccine immunology.
Immunological reviews 2011;239(1):167-77.
2010: Surender Khurana; Wanida Chearwae; Flora Castellino; Jody Manischewitz; Lisa R King; Agnieszka Honorkiewicz; Michael T Rock; Kathryn M Edwards; Giuseppe Del Giudice; Rino Rappuoli; Hana Golding
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
Science translational medicine 2010;2(15):15ra5.
2010: Arash Hassantoufighi; Henry Zhang; Matthew Sandbulte; Jin Gao; Jody Manischewitz; Lisa King; Hana Golding; Timothy M Straight; Maryna C Eichelberger
A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses.
Vaccine 2010;28(3):790-7.
2010: Surender Khurana; Swati Verma; Nitin Verma; Corey J Crevar; Donald M Carter; Jody Manischewitz; Lisa R King; Ted M Ross; Hana Golding
Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus.
PloS one 2010;5(7):e11548.
2010: Surender Khurana; Philip J Norris; Michael P Busch; Barton F Haynes; Susan Park; Pretty Sasono; Koleka Patience Mlisana; Abdool Karim Salim; Frederick Hecht; Joseph Mulenga; Elwyn Chomba; Eric Hunter; Susan Allen; George Nemo; Isaac R Rodriguez-Chavez; Joseph B Margolick; Hana Golding
HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.
Journal of clinical microbiology 2010;48(1):281-5.
2009: Marina Zaitseva; Senta M Kapnick; John Scott; Lisa R King; Jody Manischewitz; Lev Sirota; Shantha Kodihalli; Hana Golding
Application of bioluminescence imaging to the prediction of lethality in vaccinia virus-infected mice.
Journal of virology 2009;83(20):10437-47.
2009: Clement A Meseda; Anne E Mayer; Arunima Kumar; Alonzo D Garcia; Joseph Campbell; Paul Listrani; Jody Manischewitz; Lisa R King; Hana Golding; Michael Merchlinsky; Jerry P Weir
Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.
Clinical and vaccine immunology : CVI 2009;16(9):1261-71.
2009: Surender Khurana; Amorsolo Suguitan; Yonaira Rivera; Cameron P Simmons; Antonio Lanzavecchia; Federica Sallusto; Jody Manischewitz; Lisa R King; Kanta Subbarao; Hana Golding
Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.
PLoS medicine 2009;6(4):e1000049.
2008: Maryna C Eichelberger; Hana Golding; Maureen Hess; Jerry Weir; Kanta Subbarao; Catherine J Luke; Martin Friede; D Wood
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007.
Vaccine 2008;26(34):4299-303.
2007: Yong He; Jody Manischewitz; Clement A Meseda; Michael Merchlinsky; Russell Vassell; Lev Sirota; Ira Berkower; Hana Golding; Carol D Weiss
Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
The Journal of infectious diseases 2007;196(7):1026-32.
2007: Virginia L Kan; Jody Manischewitz; Lisa R King; Hana Golding
Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection.
AIDS (London, England) 2007;21(4):521-4.
2006: Jean-Michel Heraud; Yvette Edghill Spano; Victor Ayala; Irene Kalisz; Janie Parrino; Vaniambadi S Kalyanaraman; Jody Manischewitz; Lisa R King; Anna Hryniewicz; Christopher J Trindade; Meredith Hassett; Wen-Po Tsai; David Venzon; Aysegul Nalca; Monica Vaccari; Peter Silvera; Mike Bray; Barney S Graham; Hana Golding; Jay W Hooper; Genoveffa Franchini
Subunit recombinant vaccine protects against monkeypox.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(4):2552-64.
2006: Surender Khurana; James Needham; Bonnie Mathieson; Isaac R Rodriguez-Chavez; Andrew T Catanzaro; Robert T Bailer; Jerome Kim; Vicky Polonis; David A Cooper; Jan Guerin; Michael L Peterson; Marc Gurwith; Nga Nguyen; Barney S Graham; Hana Golding
Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies.
Journal of virology 2006;80(5):2092-9.
2006: Kirk H Waibel; Hana Golding; Jody Manischewitz; Lisa R King; Margaret Tuchscherer; Richard L Topolski; Douglas S Walsh
Clinical and immunological comparison of smallpox vaccine administered to the outer versus the inner upper arms of vaccinia-naive adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(4):e16-20.
2005: Marina Zaitseva; Tatiana Romantseva; Jody Manischewitz; Jiun Wang; David Goucher; Hana Golding
Increased CXCR4-dependent HIV-1 fusion in activated T cells: role of CD4/CXCR4 association.
Journal of leukocyte biology 2005;78(6):1306-17.
2005: Clement A Meseda; Alonzo D Garcia; Arunima Kumar; Anne E Mayer; Jody Manischewitz; Lisa R King; Hana Golding; Michael Merchlinsky; Jerry P Weir
Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Virology 2005;339(2):164-75.
2005: Hana Golding; Surender Khurana; Felix Yarovinsky; Lisa R King; Galina Abdoulaeva; Liselotte Antonsson; Christer Owman; Emily J Platt; David Kabat; John F Andersen; Alan Sher
CCR5 N-terminal region plays a critical role in HIV-1 inhibition by Toxoplasma gondii-derived cyclophilin-18.
The Journal of biological chemistry 2005;280(33):29570-7.
2005: Yvette Edghill Spano; Hana Golding; Jody Manischewitz; Lisa R King; Dorothy Scott; Mike Bray; Aysegul Nalca; Jay W Hooper; Chris A Whitehouse; Joern schmitz; Keith A Reimann; Genoveffa Franchini
Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.
Nature medicine 2005;11(7):740-7.
2005: Nicole A Bleckwenn; Hana Golding; William E. Bentley; Joseph Shiloach
Production of recombinant proteins by vaccinia virus in a microcarrier based mammalian cell perfusion bioreactor.
Biotechnology and bioengineering 2005;90(6):663-74.
2005: Surender Khurana; Michael Kennedy; Lisa R King; Hana Golding
Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity.
Journal of virology 2005;79(11):6791-800.
2005: Yvette Edghill Spano; Mike Bray; Chris A Whitehouse; David Miller; Eric Mucker; Jody Manischewitz; Lisa R King; Marjorie Robert-Guroff; Anna Hryniewicz; David Venzon; Clement A Meseda; Jerry Weir; Aysegul Nalca; Virginia Livingston; Jay Wells; Mark G Lewis; John W Huggins; Susan H Zwiers; Hana Golding; Genoveffa Franchini
Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.
The Journal of infectious diseases 2005;191(3):372-81.
2004: Felix Yarovinsky; John F Andersen; Lisa R King; Patricia Caspar; Julio Aliberti; Hana Golding; Alan Sher
Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii.
The Journal of biological chemistry 2004;279(51):53635-42.
2004: Nancy Eller; Hana Golding; Satoshi Inoue; Paul Beining; John Inman; Natasha Matthews; Dorothy E Scott; Basil Golding
Systemic and mucosal immunity in rhesus macaques immunized with HIV-1 peptide and gp120 conjugated to Brucella abortus.
Journal of medical primatology 2004;33(4):167-74.
2004: J C Goldsmith; Nancy Eller; Malgorzata G Mikolajczyk; Jody Manischewitz; Hana Golding; Dorothy E Scott
Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia.
Vox sanguinis 2004;86(2):125-9.
2003: Hana Golding; Julio Aliberti; Lisa R King; Jody Manischewitz; John Andersen; Jesus Valenzuela; Nathaniel R Landau; Alan Sher
Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii.
Blood 2003;102(9):3280-6.
2003: Yvette Edghill Spano; David Venzon; Tatiana S Karpova; James McNally; Janos Nacsa; Wen-Po Tsai; Elzbieta Tryniszewska; Marcin Moniuszko; Jody Manischewitz; Lisa R King; Steven J Snodgrass; John Parrish; Phillip Markham; Marsha Sowers; Derrick Martin; Mark G Lewis; Jay A Berzofsky; Igor M Belyakov; Bernard Moss; Jim Tartaglia; Mike Bray; Vanessa M Hirsch; Hana Golding; Genoveffa Franchini
Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques.
The Journal of infectious diseases 2003;188(8):1181-91.
2003: Jody Manischewitz; Lisa R King; Nicole A Bleckwenn; Joseph Shiloach; Rolf E Taffs; Michael Merchlinsky; Nancy Eller; Malgorzata G Mikolajczyk; David J Clanton; Thomas Monath; Richard Weltzin; Dorothy E Scott; Hana Golding
Development of a novel vaccinia-neutralization assay based on reporter-gene expression.
The Journal of infectious diseases 2003;188(3):440-8.
2003: Marina Zaitseva; Keith W C Peden; Hana Golding
HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors.
Biochimica et biophysica acta 2003;1614(1):51-61.
2002: Cheryl K Lapham; Tatiana Romantseva; Emanuel F Petricoin; Lisa R King; Jody Manischewitz; Marina Zaitseva; Hana Golding
CXCR4 heterogeneity in primary cells: possible role of ubiquitination.
Journal of leukocyte biology 2002;72(6):1206-14.
2002: Hana Golding; Marina Zaitseva; Eve de Rosny; Lisa R King; Jody Manischewitz; Igor Sidorov; Miroslaw K Gorny; Susan Zolla-Pazner; Dimiter S Dimitrov; Carol D Weiss
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates.
Journal of virology 2002;76(13):6780-90.
2002: Marina Zaitseva; Tatsuyoshi Kawamura; Rebecca Loomis; Harris Goldstein; Andrew Blauvelt; Hana Golding
Stromal-derived factor 1 expression in the human thymus.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(6):2609-17.
2002: Basil Golding; Nancy Eller; Lily Levy; Paul Beining; John Inman; Natasha Matthews; Dorothy E Scott; Hana Golding
Mucosal immunity in mice immunized with HIV-1 peptide conjugated to Brucella abortus.
Vaccine 2002;20(9-10):1445-50.
2001: O Scharf; Hana Golding; Lisa R King; Nancy Eller; Douglas Frazier; Basil Golding; Dorothy E Scott
Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1.
Journal of virology 2001;75(14):6558-65.
2001: Marina Zaitseva; Lisa R King; Jody Manischewitz; M Dougan; L Stevan; Hana Golding; Basil Golding
Human peripheral blood T cells, monocytes, and macrophages secrete macrophage inflammatory proteins 1alpha and 1beta following stimulation with heat-inactivated Brucella abortus.
Infection and immunity 2001;69(6):3817-26.
2001: Basil Golding; Dorothy E Scott; O Scharf; Li-Yun Huang; Marina Zaitseva; Cheryl K Lapham; Nancy Eller; Hana Golding
Immunity and protection against Brucella abortus.
Microbes and infection / Institut Pasteur 2001;3(1):43-8.
2000: Marina Zaitseva; Sherwin Lee; Cheryl K Lapham; Rolf E Taffs; L King; Tatiana Romantseva; Jody Manischewitz; Hana Golding
Interferon gamma and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection.
Blood 2000;96(9):3109-17.
2000: Y C Hu; J Kaufman; M W Cho; Hana Golding; Joseph Shiloach
Production of HIV-1 gp120 in packed-bed bioreactor using the vaccinia virus/T7 expression system.
Biotechnology progress 2000;16(5):744-50.
2000: Sherwin Lee; H L Tiffany; L King; P M Murphy; Hana Golding; Marina Zaitseva
CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor.
Journal of virology 2000;74(15):6946-52.
2000: Sherwin Lee; Cheryl K Lapham; H Chen; L King; Jody Manischewitz; Tatiana Romantseva; Howard Mostowski; Tzanko S Stantchev; Christopher C Broder; Hana Golding
Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Journal of virology 2000;74(11):5016-23.
2000: C R Yu; Keith W C Peden; Marina Zaitseva; Hana Golding; Joshua M Farber
CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck beta-15 that differ in their sensitivities to ligand.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(3):1293-305.
1999: H Asada; V Klaus-Kovtun; Hana Golding; Stephen I Katz; Andrew Blauvelt
Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures.
Journal of virology 1999;73(5):4019-28.
1999: Cheryl K Lapham; Marina Zaitseva; Sherwin Lee; T Romanstseva; Hana Golding
Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5.
Nature medicine 1999;5(3):303-8.
1999: Hana Golding; J Ouyang; Marina Zaitseva; Christopher C Broder; Dimiter S Dimitrov; Cheryl K Lapham
Increased association of glycoprotein 120-CD4 with HIV type 1 coreceptors in the presence of complex-enhanced anti-CD4 monoclonal antibodies.
AIDS research and human retroviruses 1999;15(2):149-59.
1998: IM Fernández; Hana Golding; Barry Benaissa-Trouw; NM de Vos; M Harmsen; Hans S L M Nottet; Basil Golding; Wouter C Puijk; Rob H Meloen; Harm Snippe; CA Kraaijeveld
Induction of HIV-1 IIIb neutralizing antibodies in BALB/c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV.
Vaccine 1998;16(20):1936-40.
1998: Marina Zaitseva; CF Mojcik; Daniel R Salomon; E M Shevach; Hana Golding
Co-ligation of alpha4beta1 integrin and TCR rescues human thymocytes from steroid-induced apoptosis.
International immunology 1998;10(10):1551-61.
1998: J Paul Zoeteweij; Hana Golding; Howard Mostowski; Andrew Blauvelt
Cytokines regulate expression and function of the HIV coreceptor CXCR4 on human mature dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3219-23.
1998: Dorothy E Scott; Hana Golding; Li-Yun Huang; John Inman; Basil Golding
HIV peptide conjugated to heat-killed bacteria promotes antiviral responses in immunodeficient mice.
AIDS research and human retroviruses 1998;14(14):1263-9.
1998: Marina Zaitseva; Sherwin Lee; R L Rabin; H L Tiffany; Joshua M Farber; Keith W C Peden; P M Murphy; Hana Golding
CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(6):3103-13.
1997: Marina Zaitseva; Andrew Blauvelt; Sherwin Lee; Cheryl K Lapham; V Klaus-Kovtun; Howard Mostowski; Jody Manischewitz; Hana Golding
Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection.
Nature medicine 1997;3(12):1369-75.
1997: S Lee; Harris Goldstein; Michael Baseler; Joseph W Adelsberger; Hana Golding
Human immunodeficiency virus type 1 infection of mature CD3hiCD8+ thymocytes.
Journal of virology 1997;71(9):6671-6.
1997: Sherwin Lee; Keith W C Peden; Dimiter S Dimitrov; Christopher C Broder; Jody Manischewitz; Galina Denisova; Jonathan M Gershoni; Hana Golding
Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.
Journal of virology 1997;71(8):6037-43.
1996: Cheryl K Lapham; J Ouyang; B Chandrasekhar; Nga Y Nguyen; Dimiter S Dimitrov; Hana Golding
Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines.
Science (New York, N.Y.) 1996;274(5287):602-5.
1996: Marina Zaitseva; Hana Golding; Jody Manischewitz; D Webb; Basil Golding
Brucella abortus as a potential vaccine candidate: induction of interleukin-12 secretion and enhanced B7.1 and B7.2 and intercellular adhesion molecule 1 surface expression in elutriated human monocytes stimulated by heat-inactivated B. abortus.
Infection and immunity 1996;64(8):3109-17.
1996: Cheryl K Lapham; Basil Golding; J Inman; R Blackburn; Jody Manischewitz; PF Highet; Hana Golding
Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
Journal of virology 1996;70(5):3084-92.
1995: Hana Golding; Dimiter S Dimitrov; Jody Manischewitz; Christopher C Broder; J Robinson; S Fabian; Dan R Littman; Cheryl K Lapham
Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules.
Journal of virology 1995;69(10):6140-8.
1995: Marina Zaitseva; Hana Golding; M Betts; A Yamauchi; E T Bloom; L E Butler; L Stevan; Basil Golding
Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus.
Infection and immunity 1995;63(7):2720-8.
1995: Basil Golding; J Inman; PF Highet; R Blackburn; Jody Manischewitz; N Blyveis; R D Angus; Hana Golding
Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.
Journal of virology 1995;69(6):3299-307.
1994: J Qian; V Bours; Jody Manischewitz; R Blackburn; U Siebenlist; Hana Golding
Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-kappa B DNA binding proteins.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(8):4183-91.
1994: Hana Golding; Jody Manischewitz; L Vujcic; Robert Blumenthal; Dimiter S Dimitrov
The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
Journal of virology 1994;68(3):1962-9.
1994: B Golding; Marina Zaitseva; Hana Golding
The potential for recruiting immune responses toward type 1 or type 2 T cell help.
The American journal of tropical medicine and hygiene 1994;50(4 Suppl):33-40.
1993: Hana Golding; Robert Blumenthal; Jody Manischewitz; Dan R Littman; Dimiter S Dimitrov
Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time.
Journal of virology 1993;67(11):6469-75.
1993: Hana Golding; Dimiter S Dimitrov; R Blackburn; Jody Manischewitz; Robert Blumenthal; Basil Golding
Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(6):2506-16.
1992: Hana Golding; Dimiter S Dimitrov; Robert Blumenthal
LFA-1 adhesion molecules are not involved in the early stages of HIV-1 env-mediated cell membrane fusion.
AIDS research and human retroviruses 1992;8(9):1593-8.
1992: K Hillman; J Qian; J N Siegel; Gregory Roderiquez; R Blackburn; Jody Manischewitz; Michael A Norcross; Hana Golding
Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(12):3991-8.
1992: M F Gruber; I K Hewlett; T Simms; L Vujcic; Jody Manischewitz; Hana Golding
Study of viral replication in HIV-1-infected CEM T-cell subclones which are reduced in their ability to form syncytia.
AIDS research and human retroviruses 1992;8(6):1139-46.
1992: Dimiter S Dimitrov; K Hillman; Jody Manischewitz; Robert Blumenthal; Hana Golding
Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS.
AIDS (London, England) 1992;6(3):249-56.
1992: Dimiter S Dimitrov; K Hillman; Jody Manischewitz; Robert Blumenthal; Hana Golding
Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.
Journal of virology 1992;66(1):132-8.
1992: Anu Puri; Dimiter S Dimitrov; Hana Golding; Robert Blumenthal
Interactions of CD4+ plasma membrane vesicles with HIV-1 and HIV-1 envelope glycoprotein-expressing cells.
Journal of acquired immune deficiency syndromes 1992;5(9):915-20.
1991: Dimiter S Dimitrov; Hana Golding; Robert Blumenthal
Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes.
AIDS research and human retroviruses 1991;7(10):799-805.
1991: Basil Golding; Hana Golding; S Preston; D Hernandez; P R Beining; Jody Manischewitz; L Harvath; R Blackburn; E Lizzio; T Hoffman
Production of a novel antigen by conjugation of HIV-1 to Brucella abortus: studies of immunogenicity, isotype analysis, T-cell dependency, and syncytia inhibition.
AIDS research and human retroviruses 1991;7(5):435-46.
1991: K Hillman; O Shapira-Nahor; R Blackburn; D Hernandez; Hana Golding
A polymer containing a repeating peptide sequence can stimulate T-cell-independent IgG antibody production in vivo.
Cellular immunology 1991;134(1):1-13.
1991: R Blackburn; Mario Clerici; Dean L Mann; D R Lucey; J Goedert; Basil Golding; Gene M Shearer; Hana Golding
Common sequence in HIV 1 GP41 and HLA class II beta chains can generate crossreactive autoantibodies with immunosuppressive potential early in the course of HIV 1 infection.
Advances in experimental medicine and biology 1991;303():63-9.
1991: M F Gruber; D S Webb; T L Gerrard; Howard Mostowski; L Vujcic; Hana Golding
Re-evaluation of the involvement of the adhesion molecules ICAM-1/LFA-1 in syncytia formation of HIV-1-infected subclones of a CEM T-cell leukemic line.
AIDS research and human retroviruses 1991;7(1):45-53.
1990: W I Frels; C Bordallo; Hana Golding; A Rosenberg; Stuart Rudikoff; dinah singer
Expression of a class I MHC transgene: regulation by a tissue-specific negative regulatory DNA sequence element.
The New biologist 1990;2(11):1024-33.
1990: O Shapira-Nahor; Hana Golding; L K Vujcic; S Resto-Ruiz; R L Fields; F A Robey
CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection.
Cellular immunology 1990;128(1):101-17.
1990: K Hillman; O Shapira-Nahor; M F Gruber; J Hooley; Jody Manischewitz; R Seeman; L Vujcic; S J Geyer; Hana Golding
Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(6):2131-9.
1989: Hana Golding; Gene M Shearer; K Hillman; P Lucas; Jody Manischewitz; R A Zajac; Mario Clerici; R E Gress; R N Boswell; Basil Golding
Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.
The Journal of clinical investigation 1989;83(4):1430-5.
1988: Hana Golding; F A Robey; F T Gates; W Linder; P R Beining; T Hoffman; Basil Golding
Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.
The Journal of experimental medicine 1988;167(3):914-23.
1988: dinah singer; J Hare; Hana Golding; L Flaherty; Stuart Rudikoff
Characterization of a new subfamily of class I genes in the H-2 complex of the mouse.
Immunogenetics 1988;28(1):13-21.
1987: Alfred Singer; T I Munitz; Hana Golding; Amy S Rosenberg; T Mizuochi
Recognition requirements for the activation, differentiation and function of T-helper cells specific for class I MHC alloantigens.
Immunological reviews 1987;98():143-70.
1985: Hana Golding; J McCluskey; T I Munitz; Ronald N Germain; David Margulies; Alfred Singer
T-cell recognition of a chimaeric class II/class I MHC molecule and the role of L3T4.
Nature 1985;317(6036):425-7.
1985: Hana Golding; T I Munitz; Alfred Singer
Characterization of antigen-specific, Ia-restricted, L3T4+ cytolytic T lymphocytes and assessment of thymic influence on their self specificity.
The Journal of experimental medicine 1985;162(3):943-61.
1985: T Mizuochi; Hana Golding; Amy S Rosenberg; L H Glimcher; Thomas R Malek; A Singer
Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self.
The Journal of experimental medicine 1985;162(2):427-43.
1983: B Golding; Hana Golding; P G Foiles; J I Morton
CBA/N X-linked defect delays expression of the Y-linked accelerated autoimmune disease in BXSB mice.
Journal of immunology (Baltimore, Md. : 1950) 1983;130(3):1043-6.
1982: Hana Golding; P G Foiles; Marvin B Rittenberg
Partial reconstitution of TNP-Ficoll responses and IgG3 expression in Xid mice undergoing graft-vs-host reaction.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(6):2641-6.
1982: Hana Golding; Marvin B Rittenberg
In vivo allogeneic effects: shift in the isotype profile of primary TI-2 responses in mice undergoing graft-vs-host reaction.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(5):1878-82.
1982: Hana Golding; Marvin B Rittenberg
In vitro and in vivo allogeneic effects: differential modulation of B cell subpopulations.
Journal of immunology (Baltimore, Md. : 1950) 1982;128(4):1625-30.
1982: M L Cohn; Hana Golding; Marvin B Rittenberg
Antibodies to cell surface antigens detected by a rapid spot test using ethidium bromide.
Journal of immunological methods 1982;49(1):75-82.
1981: B Golding; S P Chang; Hana Golding; Richard Jones; K L Pratt; D R Burger; Marvin B Rittenberg
Human lymphocytes can generate thymus-independent as well as thymus-dependent anti-hapten plaque-forming cell responses in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(1):220-4.
1980: Hana Golding; Marvin B Rittenberg
Differential sensitivity of IgG memory subpopulations to allogeneic thymocytes: positive and negative signals.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(3):1284-90.